Dr. Kuklo, a former U.S. Army surgeon, was accused by the Army of falsifying data in a clinical trial involving Infuse, a Medtronic bone-growth product. The results of his study were published in 2008 in a British medical journal but were later retracted by the journal.
During the time of the study, Dr. Kuklo served as a consultant to Medtronic, receiving more than $800,000 in fees over the course of three years, according to the report. Medtronic stated that it was not involved in the study.
Read the Wall Street Journal’s report on Dr. Kuklo’s resignation.
